Riskpilot← Back to searchSign inGet full accessTempus Sweden AB
ABIn liquidationOrg 5590658158Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20160 employees
Revenue 2021
SEK 0
EBITDA margin
—
+89% vs 2020
Equity ratio
29.0%
Financial strength
Net profit 2021
SEK -6K
+63% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +89% |
| Net profit | SEK -6K | +63% |
| Total assets | SEK 100K | -67% |
| Equity | SEK 29K | -17% |
| Employees | 0 | — |
Legal name
Tempus Sweden AB
Org number
5590658158
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8 juni 2016
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-06-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva försäljning av system för sjukhus som möjliggör transport av kliniska tester genom rörledningar (s.k. pipelines) mellan sjukhusavdelningar och laboratoriet samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | 1 593 | 2 200 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 0 | 0 | 1 | −9 | −1 |
| Depreciation & amort. | — | — | −0 | −0 | −0 |
| EBIT | 0 | 0 | 1 | −9 | −1 |
| Net financials | — | — | −1 | −6 | −5 |
| Profit before tax | 0 | 0 | 0 | −16 | −6 |
| Tax | — | — | −0 | −0 | −0 |
| Net profit | — | — | 0 | −16 | −6 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | — | — | 844 | 304 | 100 |
| Equity | — | — | 50 | 35 | 29 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | — | — | 794 | 269 | 71 |
| Total debt | — | — | 794 | 269 | 71 |
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
20172021
Equity ratio
29.0%
This company
38.2%
Market median
-24% vs market
20172021
Return on equity
-20.7%
This company
18.4%
Market median
-213% vs market
20172021
Net profit margin
-600000.0%
This company
8.1%
Market median
-7407507% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
2.45×
This company
0.62×
Market median
-295% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-06-01 – 2017-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AP Liquidator | Liquidator | 2022 |
| Former (3) | ||
LE Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2022 |
CE Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2022 |
PM Chief Executive Officer | Chief Executive Officer | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Deputy Board Member | 2020 – 2022 | |
| Chairman | 2020 – 2020 | |
| Board of Directors | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tempus Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lina Eva André | Authorized Recipient of Service | 0 companies |
| Charlotte Elisabeth Forssander | Authorized Recipient of Service | 0 companies |
| Anna Petronella Hallberg | Liquidator | 0 companies |
| Peter Møller Sørensen | Chief Executive Officer | 0 companies |
| Timo Schretzmair | Deputy Board Member | 0 companies |
| Daniel Blak | Chairman | 0 companies |
| Finn Dyhre Hansen | Board of Directors | 0 companies |